Profil
Cecilia Hofvander is currently Vice President-Investor Relations at BioInvent International AB since 2021.
Former positions include Director-Investor Relations & Communications at Abliva AB, Assistant Director-Investor Relations at Active Biotech AB, and Communications Director at Alligator Bioscience AB from 2017 to 2021.
Education includes an undergraduate degree from the University of Lund.
Postes actifs de Cecilia Hofvander
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Investor Relations Contact | 01/02/2021 |
Anciens postes connus de Cecilia Hofvander
| Sociétés | Poste | Fin |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Investor Relations Contact | 01/02/2021 |
| ABLIVA AB | Investor Relations Contact | - |
| ACTIVE BIOTECH AB | Public Communications Contact | - |
Formation de Cecilia Hofvander
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Alligator Bioscience AB
Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















